Drug intelligence / Profile preview

let-7a microRNA mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral, Subcutaneous
01

Overview

The let-7a microRNA mimic is a research-stage RNA-based therapeutic designed to replicate the function of the endogenous tumor suppressor microRNA let-7a. As a member of the let-7 family, it plays a critical role in regulating genes involved in cell proliferation, apoptosis, and oncogenesis. The mimic is primarily investigated for its ability to downregulate oncogenic targets such as KRAS and signal transducers like STAT3, as well as pro-apoptotic genes like Fas and FasL. Preclinical research has explored its potential in fertility preservation (protecting ovarian follicles from chemotherapy-induced damage), oncology (as a tumor suppressor in hepatocellular carcinoma and KRAS-mutant cancers), and immunotherapy. Delivery strategies include liposomal transfection, cholesterol conjugation, and gold nanoparticles. It is currently an academic research tool without a commercial sponsor or clinical-stage development.

Other names
let-7a microRNAlet7a microRNAlet 7a microRNAlet-7a miRNA mimiclet7a miRNA mimiclet 7a miRNA mimic
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)Fas cell surface death receptor mRNA 3′-untranslated regionKRAS (Kirsten rat sarcoma viral oncogene homolog)

Beyond the preview

Go deeper on let-7a microRNA mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on let-7a microRNA mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call